Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2013

View Archived Issues

Serum IL-33 levels predict rheumatoid arthritis response to rituximab

MOD-6030 shows promise in animal models of obesity and type 2 diabetes

Uncovering new genetic and clinical biomarkers of human disease

Vaxart reports preclinical findings for new H7N9 avian influenza vaccine

ViroPharma provides update on phase II studies of maribavir

EntreMed files new drug global trial application for ENMD-2076 in China

Navidea Biopharmaceuticals begins phase III NAV-4694 trial

Boehringer Ingelheim synthesizes new GPR119 receptor agonists

AstraZeneca acquires Pearl Therapeutics

Verastem completes first stage of VS-6063 combination trial

FDA approves Exelon patch to treat all stages of Alzheimer's disease

Bisono Tape transdermal patch approved in Japan

Soliris receives FDA orphan drug designation for neuromyelitis optica

Drisapersen receives FDA breakthrough therapy designation

UGP-302 evaluated in animal models of obesity and diabetes

Amgen presents novel tankyrase inhibitor

Approval of Lemtrada for relapsing remitting MS recommended in Europe

Nexavar submitted in U.S and E.U. for radioactive iodine-refractory differentiated thyroid cancer

EMA recommends approval of two GSK cancer drugs

European CHMP recommends approval of two infliximab biosimilars

Takeda withdraws MAA for peginesatide in Europe

FDA issues complete response for Xarelto to reduce the risk of stent thrombosis in ACS

Regorafenib recommended for approval in the E.U.

CHMP issues positive opinion on two variations for Velcade

Autifony Therapeutics presents new potassium channel modulators

Merck & Co. receives FDA complete response letter for suvorexant

Cadila Healthcare synthesizes novel renin inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...